Weight gain in patients starting Dolutegravir-based ART according to baseline CD4 count after 48 weeks of follow up

Effects of different integrase strand transfer inhibitors on body weight in patients with HIV/AIDS: a network meta-analysis

(2022) Ruojing Bai et al.   BMC INFECTIOUS DISEASES

Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study)

(2022) Cristina Gómez-Ayerbe et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Weight Gain among Treatment-naïve Persons with HIV Receiving Dolutegravir in Kenya

(2022) Kassem Bourgi et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide

(2022) Frank J. Palella et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir- and Tenofovir-containing Regimens

(2021) Zinhle Cindi et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Long-term weight gain after initiating combination antiretroviral therapy in treatment-naïve Asian people living with human immunodeficiency virus

(2021) Naokatsu Ando et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

(2021) Loveleen Bansi-Matharu et al.   Lancet HIV

No overall impact on rate of weight gain with integrase inhibitor‐containing regimens in antiretroviral‐naïve adults

(2021) James E. Burns et al.   HIV MEDICINE

Factors associated with weight gain in people treated with dolutegravir

(2020) Lucia Taramasso et al.   Open Forum Infectious Diseases

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

(2020) Willem D F Venter et al.   Lancet HIV

Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era

(2020) Stephanie A. Ruderman et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy

(2019) Kassem Bourgi et al.   CLINICAL INFECTIOUS DISEASES

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

(2019) Paul E Sax et al.   CLINICAL INFECTIOUS DISEASES